Clinical observation of implanting 5-fluorouracil while surgery to liver cancer

Ting LIANG,Jinming ZHAO,Hao GU,Jinhui ZHANG
DOI: https://doi.org/10.3969/j.issn.1009-5551.2014.12.019
2014-01-01
Abstract:Objective To Investigate the release of liver cancer during implantation for regional chemothera-py agent fluorouracil safety and clinical efficacy.Methods 54 cases of liver cancer patients who can suf-fered surgical exploration and be cut completely were Collected from 2011 to 2012,and were randomized into treatment group and control group.After surgery,patients in treatment group were implanted with 5-fluorouracil into the incisal edge of liver while patients in control group without any chemotherapy.Draw-blood were taken to all patients on the 1st day after admission to hospital and 14th day after surgery.Ad-verse reaction,routine blood test,liver function,renal function,tumor maker were observed and com-pared between the two groups two weeks after surgery.Results (1)There is no significant different be-tween the two group of adverse reaction,routine blood test,liver function and renal function (P >0.05). (2)There is significant different between the two group of AFP two weeks after surgery (P <0.05).Con-clusion Implanted with 5-fluorouracil into the incisal edge of liver while surgery has no significant adverse reaction and harmful effects to routine blood test,liver function and renal function,and can reduce AFP significantly.It can be recognized as a Safe and useful partial chemotherapy medicine.
What problem does this paper attempt to address?